Telemedicine-Based Management of Oral Anticoagulation Therapy: Systematic Review and Meta-analysis (Preprint)

Author:

Braga Ferreira LetíciaORCID,Lanna de Almeida RodrigoORCID,Arantes AlairORCID,Abdulazeem HebatullahORCID,Weerasekara IshankaORCID,Ferreira Leticia Santos Dias NorbertoORCID,Fonseca de Almeida Messias LuanaORCID,Siuves Ferreira Couto LucianaORCID,Parreiras Martins Maria AuxiliadoraORCID,Suelen Antunes NúbiaORCID,Fonseca Cândido Raissa CarolinaORCID,Rosa Ferreira SamuelORCID,Guerra Pezzini Assis TatiORCID,Marques Pedroso ThaisORCID,Boersma EricORCID,Ribeiro AntonioORCID,Marcolino Milena SorianoORCID

Abstract

BACKGROUND

Oral anticoagulation is the cornerstone treatment of several diseases. Its management is often challenging, and different telemedicine strategies have been implemented to support it.

OBJECTIVE

The aim of the study is to systematically review the evidence on the impact of telemedicine-based oral anticoagulation management compared to usual care on thromboembolic and bleeding events.

METHODS

Randomized controlled trials were searched in 5 databases from inception to September 2021. Two independent reviewers performed study selection and data extraction. Total thromboembolic events, major bleeding, mortality, and time in therapeutic range were assessed. Results were pooled using random effect models.

RESULTS

In total, 25 randomized controlled trials were included (n=25,746 patients) and classified as moderate to high risk of bias by the Cochrane tool. Telemedicine resulted in lower rates of thromboembolic events, though not statistically significant (n=13 studies, relative risk [RR] 0.75, 95% CI 0.53-1.07; <i>I</i><sup>2</sup>=42%), comparable rates of major bleeding (n=11 studies, RR 0.94, 95% CI 0.82-1.07; <i>I</i><sup>2</sup>=0%) and mortality (n=12 studies, RR 0.96, 95% CI 0.78-1.20; <i>I</i><sup>2</sup>=11%), and an improved time in therapeutic range (n=16 studies, mean difference 3.38, 95% CI 1.12-5.65; <i>I</i><sup>2</sup>=90%). In the subgroup of the multitasking intervention, telemedicine resulted in an important reduction of thromboembolic events (RR 0.20, 95% CI 0.08-0.48).

CONCLUSIONS

Telemedicine-based oral anticoagulation management resulted in similar rates of major bleeding and mortality, a trend for fewer thromboembolic events, and better anticoagulation quality compared to standard care. Given the potential benefits of telemedicine-based care, such as greater access to remote populations or people with ambulatory restrictions, these findings may encourage further implementation of eHealth strategies for anticoagulation management, particularly as part of multifaceted interventions for integrated care of chronic diseases. Meanwhile, researchers should develop higher-quality evidence focusing on hard clinical outcomes, cost-effectiveness, and quality of life.

CLINICALTRIAL

PROSPERO International Prospective Register of Systematic Reviews CRD42020159208; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=159208

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3